← Leaderboards
Henry Linn
La Biomed Res Inst/ Harbor Ucla Med Ctr
$238,960
Attributed
$238,960
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$238,960 · 1
By mechanism
M01$238,960 · 1
Top collaborators
No co-investigators on record.
Most similar at La Biomed Res Inst/ Harbor Ucla Med Ctr
Same institution · by research overlap
- Shalendar Bhasin$66,433,688
- Ronald Sherwin Swerdloff$7,352,119
- Lin Chang$6,128,049
- Kenneth K Chan$1,473,754
- Mina Desai$3,785,165
Others in their field
Top investigators on “Biological Transport”
- Mine Cicek · Mayo Clinic Rochester$80,157,953
- Stephen Norman Thibodeau · Mayo Clinic Rochester$70,215,522
- Richard C Boucher · University Of North Carolina Chapel Hill$43,810,853
- Merit E Cudkowicz · Massachusetts General Hospital$41,890,591
- Dennis L Matthews · University Of California-Davis$39,323,652
- Jan C Buckner · Mayo Clinic Coll Of Medicine, Rochester$36,571,089
Research focus
Biological TransportClinical ResearchDiarrheaFatty AcidsGastrointestinal Disorder ChemotherapyHuman SubjectInflammatory Bowel DiseasesMedical ComplicationOral AdministrationPharmacokinetics
Grant awards (4)
FATTY ACID INCREASES DRUG BIOAVAILABILITY IN IBD PATIENTS WITH RAPID TRANSIT$237,978
M01 · FY2001 · RR
FATTY ACID INCREASES DRUG BIOAVAILABILITY IN IBD PATIENTS WITH RAPID TRANSIT$982
M01 · FY2000 · RR
FATTY ACID INCREASES DRUG BIOAVAILABILITY IN IBD PATIENTS WITH RAPID TRANSIT$0
M01 · FY2000 · RR
FATTY ACID INCREASES DRUG BIOAVAILABILITY IN IBD PATIENTS WITH RAPID TRANSIT$0
M01 · FY2000 · RR